Rhenman & Partners Asset Management AB
Filing Date
Global Rank
#2,002
/ 8,605
▼ 252
· as of Mar 2026
Top Industry
Biotechnology
36.7%
3Y Alpha vs SPY
-7.2%
Period ended 3 months ago
Filed May 14, 2026 · 56d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+46.6%
SPY
+76.5%
Annualised alpha
-7.3%
Max drawdown
−19.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
86 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
4.8%
+0.4 pts
Top 5
19.5%
+1.7 pts
Top 10
32.0%
+2.6 pts
HHI
192
Diversified+13
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $810,489,947 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | +460,000 | 2,055,327 | $7,214,197 | |
| OSCR | Oscar Health, Inc. | +400,000 | 660,000 | $7,570,200 | |
| AVR | Anteris Technologies Global Corp. | +200,000 | 1,438,625 | $7,984,368 | |
| BSX | Boston Scientific Corp | +193,793 | 625,000 | $39,218,750 | |
| STVN | Stevanato Group S.p.A. | +127,651 | 274,676 | $3,776,795 | |
| MLYS | Mineralys Therapeutics, Inc. | +120,500 | 263,071 | $7,126,593 | |
| ADPT | Adaptive Biotechnologies Corp | +115,000 | 720,000 | $9,993,600 | |
| DNLI | Denali Therapeutics Inc. | +99,000 | 199,000 | $3,820,800 | |
| VKTX | Viking Therapeutics, Inc. | +77,000 | 160,000 | $5,206,400 | |
| GH | Guardant Health, Inc. | +65,000 | 145,000 | $13,393,650 | |
| ATEC | Alphatec Holdings, Inc. | +50,000 | 70,000 | $761,600 | |
| INSM | INSMED Inc | +46,175 | 159,760 | $26,123,955 | |
| ALHC | Alignment Healthcare, Inc. | +44,000 | 1,053,450 | $18,561,789 | |
| GILD | Gilead Sciences, Inc. | +41,600 | 167,750 | $23,379,317 | |
| OCUL | Ocular Therapeutix, Inc | +40,000 | 305,000 | $2,583,350 | |
| IQV | Iqvia Holdings Inc. | +26,500 | 53,000 | $9,038,620 | |
| RPRX | Royalty Pharma plc | +26,500 | 233,000 | $11,177,010 | |
| ELV | Elevance Health, Inc. | +17,300 | 32,300 | $9,455,825 | |
| BIIB | Biogen Inc. | +16,750 | 109,100 | $20,001,303 | |
| NTRA | Natera, Inc. | +11,100 | 51,600 | $10,319,484 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | +9,230 | 43,485 | $19,417,791 | |
| BBIO | BridgeBio Pharma, Inc. | +9,000 | 90,600 | $6,727,956 | |
| TMO | Thermo Fisher Scientific Inc. | +7,700 | 41,340 | $20,319,850 | |
| IDYA | IDEAYA Biosciences, Inc. | +5,500 | 255,500 | $8,513,260 | |
| STE | STERIS plc | +5,500 | 11,500 | $2,542,995 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KURA | Kura Oncology, Inc. | −600,500 | 271,500 | $2,207,295 | |
| COO | Cooper Companies, Inc. | −277,500 | 50,000 | $3,575,000 | |
| NRIX | Nurix Therapeutics, Inc. | −224,000 | 313,500 | $4,859,250 | |
| MDT | Medtronic plc | −206,000 | 90,000 | $7,798,500 | |
| DOCS | Doximity, Inc. | −188,942 | 183,808 | $4,282,726 | |
| BTSG | BrightSpring Health Services, Inc. | −148,000 | 50,000 | $2,130,500 | |
| PRCT | PROCEPT BioRobotics Corp | −136,000 | 475,000 | $11,879,750 | |
| STOK | Stoke Therapeutics, Inc. | −133,000 | 83,000 | $2,702,480 | |
| GKOS | GLAUKOS Corp | −126,000 | 84,000 | $9,043,440 | |
| MLTX | MoonLake Immunotherapeutics | −124,500 | 239,500 | $4,464,280 | |
| XENE | Xenon Pharmaceuticals Inc. | −111,000 | 28,000 | $1,628,200 | |
| SNDX | Syndax Pharmaceuticals Inc | −107,750 | 379,250 | $8,859,280 | |
| RLAY | Relay Therapeutics, Inc. | −100,000 | 360,000 | $3,582,000 | |
| ALGN | Align Technology Inc | −91,500 | 7,500 | $1,285,725 | |
| EHC | Encompass Health Corp | −90,000 | 56,263 | $5,442,319 | |
| NUVL | Nuvalent, Inc. | −82,150 | 81,200 | $8,318,940 | |
| PNTG | Pennant Group, Inc. | −81,947 | 275,399 | $8,394,161 | |
| DHR | Danaher Corp /De/ | −81,000 | 18,052 | $3,422,659 | |
| IMCR | Immunocore Holdings plc | −67,554 | 85,724 | $2,584,578 | |
| IONS | Ionis Pharmaceuticals Inc | −65,600 | 92,900 | $6,975,861 | |
| AXSM | Axsome Therapeutics, Inc. | −51,000 | 63,800 | $10,783,476 | |
| PODD | Insulet Corp | −47,000 | 14,000 | $2,937,760 | |
| VCEL | Vericel Corp | −47,000 | 70,000 | $2,251,900 | |
| ABBV | AbbVie Inc. | −39,000 | 71,575 | $15,566,846 | |
| LIVN | LivaNova PLC | −35,000 | 155,000 | $9,851,800 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SYK | Stryker Corp | 47,800 | $15,706,602 | |
| VEEV | Veeva Systems Inc | 85,300 | $14,983,798 | |
| ABT | Abbott Laboratories | 112,000 | $11,499,040 | |
| WAY | Waystar Holding Corp. | 342,566 | $8,259,266 | |
| APGE | Apogee Therapeutics, Inc. | 75,000 | $6,312,750 | |
| CAH | Cardinal Health Inc | 27,000 | $5,705,370 | |
| NKTR | Nektar Therapeutics | 59,000 | $4,245,050 | |
| SION | Sionna Therapeutics, Inc. | 87,500 | $3,507,875 | |
| ESPR | Esperion Therapeutics, Inc. | 985,000 | $2,698,900 | |
| NVCR | NovoCure Ltd | 70,000 | $763,000 | |
| CMPX | Compass Therapeutics, Inc. | 115,113 | $608,947 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
19 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | 420,000 | $21,268,800 | |
| PEN | Penumbra Inc | 31,500 | $9,793,665 | |
| APLS | Apellis Pharmaceuticals, Inc. | 374,450 | $9,406,184 | |
| ACLX | Arcellx, Inc. | 133,500 | $8,704,200 | |
| BRKR | Bruker Corp | 147,315 | $6,940,009 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 35,000 | $3,746,400 | |
| RDNT | RadNet, Inc. | 47,000 | $3,353,450 | |
| INSP | Inspire Medical Systems, Inc. | 35,800 | $3,301,834 | |
| JANX | Janux Therapeutics, Inc. | 225,377 | $3,110,202 | |
| PRVA | Privia Health Group, Inc. | 125,000 | $2,963,750 | |
| CYTK | Cytokinetics Inc | 44,375 | $2,819,587 | |
| XNCR | Xencor Inc | 165,750 | $2,537,632 | |
| CNTA | Centessa Pharmaceuticals plc | 100,000 | $2,501,000 | |
| TGTX | Tg Therapeutics, Inc. | 73,250 | $2,183,582 | |
| BNTX | BioNTech SE | 20,870 | $1,986,824 | |
| WST | West Pharmaceutical Services Inc | 7,000 | $1,925,980 | |
| CNC | Centene Corp | 46,231 | $1,902,405 | |
| QURE | uniQure N.V. | 79,375 | $1,899,443 | |
| IRTC | iRhythm Holdings, Inc. | 7,000 | $1,242,080 | |
| No positions match the current search. | ||||
86 positions ·
$810,489,947 total
· as of Mar 31, 2026
Showing 1–50
of 86 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 625,000 | $39,218,750 | 4.84% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 48,100 | $37,163,984 | 4.59% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 33,715 | $31,010,045 | 3.83% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 159,760 | $26,123,955 | 3.22% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 336,500 | $24,167,430 | 2.98% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Added | 167,750 | $23,379,317 | 2.88% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 41,340 | $20,319,850 | 2.51% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 109,100 | $20,001,303 | 2.47% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Added | 43,485 | $19,417,791 | 2.40% | |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
Added | 1,053,450 | $18,561,789 | 2.29% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 36,846 | $16,985,637 | 2.10% | |
| COR |
Cencora, Inc.
Healthcare
|
Reduced | 52,375 | $16,453,082 | 2.03% | |
| SYK |
Stryker Corp
Healthcare
|
NEW | 47,800 | $15,706,602 | 1.94% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 71,575 | $15,566,846 | 1.92% | |
| VEEV |
Veeva Systems Inc
Healthcare
|
NEW | 85,300 | $14,983,798 | 1.85% | |
| MCK |
Mckesson Corp
Healthcare
|
Reduced | 16,850 | $14,581,316 | 1.80% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Added | 75,890 | $14,347,004 | 1.77% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Added | 145,000 | $13,393,650 | 1.65% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 100,841 | $13,284,793 | 1.64% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 163,000 | $13,053,040 | 1.61% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 24,050 | $12,589,453 | 1.55% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Reduced | 45,500 | $12,311,845 | 1.52% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Reduced | 475,000 | $11,879,750 | 1.47% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 207,000 | $11,693,430 | 1.44% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 112,000 | $11,499,040 | 1.42% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 34,465 | $11,403,434 | 1.41% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Added | 233,000 | $11,177,010 | 1.38% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 63,800 | $10,783,476 | 1.33% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 51,600 | $10,319,484 | 1.27% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Reduced | 54,000 | $10,190,340 | 1.26% | |
| ADPT |
Adaptive Biotechnologies Corp
Healthcare
|
Added | 720,000 | $9,993,600 | 1.23% | |
| LIVN |
LivaNova PLC
Healthcare
|
Reduced | 155,000 | $9,851,800 | 1.22% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 32,300 | $9,455,825 | 1.17% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Held | 144,500 | $9,060,150 | 1.12% | |
| GKOS |
GLAUKOS Corp
Healthcare
|
Reduced | 84,000 | $9,043,440 | 1.12% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 53,000 | $9,038,620 | 1.12% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 379,250 | $8,859,280 | 1.09% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 92,605 | $8,554,849 | 1.06% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 255,500 | $8,513,260 | 1.05% | |
| PNTG |
Pennant Group, Inc.
Healthcare
|
Reduced | 275,399 | $8,394,161 | 1.04% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 81,200 | $8,318,940 | 1.03% | |
| WAY |
Waystar Holding Corp.
Healthcare
|
NEW | 342,566 | $8,259,266 | 1.02% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Added | 1,438,625 | $7,984,368 | 0.99% | |
| MDT |
Medtronic plc
Healthcare
|
Reduced | 90,000 | $7,798,500 | 0.96% | |
| OSCR |
Oscar Health, Inc.
Healthcare
|
Added | 660,000 | $7,570,200 | 0.93% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Added | 2,055,327 | $7,214,197 | 0.89% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 263,071 | $7,126,593 | 0.88% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 92,900 | $6,975,861 | 0.86% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 81,627 | $6,850,137 | 0.85% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 90,600 | $6,727,956 | 0.83% |